Source: International Congress 2018 – New predictors of morbidity and mortality in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Bragman (London, United Kingdom), A. Young (London, United Kingdom), D. Hawkes (London, United Kingdom), D. Alexander (London, United Kingdom), J. Hurst (London, United Kingdom). Disease progression patterns in COPD. 2139

Member's Comments

No comment yet.

Related content which might interest you: Disease progression according to IPF phenotype Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Disease severity in COPD patients Source: Annual Congress 2003 - Staging and outcome in COPD Year: 2003 Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort Source: International Congress 2015 – Multidimensional analysis of respiratory problems Year: 2015 Do GOLD stages of COPD severity really correspond to differences in health status? Source: Eur Respir J 2003; 22: 444-449 Year: 2003 COPD: CardiOPulmonary Disease? Source: Eur Respir J 2013; 41: 1241-1243 Year: 2013 Short telomere length and its association with risk for COPD and emphysema severity: Korean Obstructive Lung Disease (KOLD) cohort study Source: International Congress 2017 – Markers of COPD progression Year: 2017 Late Breaking Abstract - Disease trajectories in GOLD B chronic obstructive pulmonary disease (COPD) patients  – nationwide data from Denmark Source: Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes Year: 2021 Disease specific knowledge in Tunisian COPD patients Source: International Congress 2018 – COPD around the world Year: 2018 Disease progression at 12 months does not predict future outcomes in IPF patients: Analysis from the Australian IPF Registry Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Disease progression and changes in risk groups' classification over a period of one year in the GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care Year: 2014 Chronic Obstructive Pulmonary Disease (COPD) in patients of Chinese ethnicity reveal clinically relevant phenotypes Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 Disease pathology in interstitial lung disease Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021 Tree years survival rates of COPD patients that hospitalized for acute excecerbation of COPD Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Prevalence of Poor Disease Control in Patients with severe COPD according to GOLD 2021 Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases Year: 2021 Cardiovascular disease in COPD Source: Eur Respir Monogr 2020; 88: 47-65 Year: 2020 Frequency of depression in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Lung function reversibility as a predictor of disease progression in COPD Source: International Congress 2017 – Markers of COPD progression Year: 2017 Chest wall volume regulation during exercise in COPD patients with GOLD stages II to IV Source: Eur Respir J 2008; 32: 42-52 Year: 2008